News
| 3 min read
ABIONYX achieves positive clinical results with CER-001 in familial lecithin–cholesterol acyltransferase deficiency
| 3 min read
Oncopeptides’ Pepaxto has been approved for patients with triple-class refractory multiple myeloma
| 2 min read
Thermo Fisher has completed the acquisition of Mesa Biotech and its Accula System PCR testing platform
| 3 min read
TG Therapeutics' GENUINE trial shows that ublituximab plus ibrutinib improves survival in patients with chronic lymphocytic leukemia
| 2 min read
INOVIO, QIAGEN expand their existing collaboration to cover companion diagnostics for INVOIO's HPV therapies
| 2 min read
UCLA researchers to select candidates for development with Xencor’s modular XmAb platforms
| 3 min read
Ibrexafungerp on track for FDA approval in June for vaginal yeast infections
| 3 min read
Study finds combination therapy with NAMPT inhibitors and STING agonists can suppress pancreatic tumor growth in mice
| 2 min read
Eli Lilly's glucagon-like peptide-1 receptor agonist reduced A1C and body weight in adults with type 2 diabetes in Phase 3 SURPASS trials
| 2 min read
The collaboration plans to create stabilized live microbiota-based formulations for treating bacterial vaginosis
| 3 min read
Phase 1/2 trial will assess safety and efficacy of RECCE 327 against broad range of infectious diseases on chronic burn wounds
| 3 min read
Denali Therapeutics reports positive three-month data from Phase 1/2 study of DNL310 in patients with Hunter syndrome
